Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 580

The DOI matches its Crossref record.

One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon

Open access
Lieberman, David A., Harford, William V., Ahnen, Dennis J., Provenzale, Dawn, Sontag, Stephen J., Schnell, Thomas G., Chejfec, Gregorio, Campbell, Donald R., Durbin, Theodore E., Bond, John H., Nelson, Douglas B., Ewing, Stephen L., Triadafilopoulos, George, Ramirez, Francisco C., Lee, John G., Collins, Judith F., Fennerty, M. Brian, Johnston, Tiina K., Corless, Christopher L., McQuaid, Kenneth R., Garewal, Harinder, Sampliner, Richard E., Morales, Thomas G., Fass, Ronnie, Smith, Robert E., Maheshwari, Yogesh, Weiss, David G.·2001·New England Journal of Medicine

Abstract

BACKGROUND: Fecal occult-blood testing and sigmoidoscopy have been recommended for screening for colorectal cancer, but the sensitivity of such combined testing for detecting neoplasia is uncertain. At 13 Veterans Affairs medical centers, we performed colonoscopy to determine the prevalence of neoplasia and the sensitivity of one-time screening with a fecal occult-blood test plus sigmoidoscopy. METHODS: Asymptomatic subjects (age range, 50 to 75 years) provided stool specimens on cards from three consecutive days for fecal occult-blood testing, which were rehydrated for interpretation. They then underwent colonoscopy. Sigmoidoscopy was defined in this study as examination of the rectum and sigmoid colon during colonoscopy, and sensitivity was estimated by determining how many patients with advanced neoplasia had an adenoma in the rectum or sigmoid colon. Advanced colonic neoplasia was defined as an adenoma 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasive cancer. Classification of subjects according to the findings was based on the most advanced lesion. RESULTS: A total of 2885 subjects returned the three specimen cards for fecal occult-blood testing and underwent a complete colonoscopic examination. A total of 23.9 percent of subjects with advanced neoplasia had a positive test for fecal occult blood. As compared with subjects who had a negative test for fecal occult blood, the relative risk of advanced neoplasia in subjects who had a positive test was 3.47 (95 percent confidence interval, 2.76 to 4.35). Sigmoidoscopy identified 70.3 percent of all subjects with advanced neoplasia. Combined one-time screening with a fecal occult-blood test and sigmoidoscopy identified 75.8 percent of subjects with advanced neoplasia. CONCLUSIONS: One-time screening with both a fecal occult-blood test with rehydration and sigmoidoscopy fails to detect advanced colonic neoplasia in 24 percent of subjects with the condition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa010328

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 580

Metadata

Authors
Lieberman, D. A., Harford, W. V., Ahnen, D. J., Provenzale, D., Sontag, S. J., Schnell, T. G., Chejfec, G., Campbell, D. R., Durbin, T. E., Bond, J. H., Nelson, D. B., Ewing, S. L., Triadafilopoulos, G., Ramirez, F. C., Lee, J. G., Collins, J. F., Fennerty, M. B., Johnston, T. K., Corless, C. L., McQuaid, K. R., Garewal, H., Sampliner, R. E., Morales, T. G., Fass, R., Smith, R. E., Maheshwari, Y., & Weiss, D. G.
Venue
New England Journal of Medicine
Published
2001-08-23
Volume
345
Issue
8
Pages
555-560
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1968605703
Cited by
580
References
0
FWCI
19.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon. https://app.cochat.ai/papers/10.1056/nejmoa010328
The paper
Lieberman, D. A., Harford, W. V., Ahnen, D. J., Provenzale, D., Sontag, S. J., Schnell, T. G., Chejfec, G., Campbell, D. R., Durbin, T. E., Bond, J. H., Nelson, D. B., Ewing, S. L., Triadafilopoulos, G., Ramirez, F. C., Lee, J. G., Collins, J. F., Fennerty, M. B., Johnston, T. K., Corless, C. L., . . . Weiss, D. G. (2001). One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon. New England Journal of Medicine. https://doi.org/10.1056/nejmoa010328

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.